Aoxing Pharmaceutical Company (AOXG) Income Statement
Aoxing Pharmaceutical Company Income Statement
Last quarter (Q2 2026), Aoxing Pharmaceutical Company's total revenue was $17.21K, a decrease of 99.77% from the same quarter last year. In Q2, Aoxing Pharmaceutical Company's net income was $-11.20K. See Aoxing Pharmaceutical Company’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Q2 26 | Q1 26 | Q3 17 | Q2 17 | Q1 17 |
|---|---|---|---|---|---|
| $ 17.21K | $ 2.08K | $ 5.70M | $ 8.01M | $ 7.57M | |
| $ 17.00K | $ 0.00 | $ 4.42M | $ 6.30M | $ 6.05M | |
| $ 28.20K | $ 4.52K | $ 3.54M | $ 6.06M | $ 4.35M | |
| Depreciation and Amortization | $ 0.00 | $ 0.00 | $ 242.79K | $ 252.16K | $ 244.54K |
| $ -11.20K | $ -2.44K | $ 1.12M | $ 502.70K | $ 1.95M | |
| $ -11.20K | $ -2.44K | $ 878.40K | $ 233.20K | $ 1.70M | |
| $ 0.00 | $ 0.00 | $ -581.20K | $ -623.05K | $ -660.67K | |
| $ -11.20K | $ -2.44K | $ 297.20K | $ -389.86K | $ 1.04M | |
| $ -11.20K | $ -2.44K | $ 132.14K | $ -43.45K | $ 346.08K | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.00 | $ 0.00 | $ 0.00 | $ -0.00 | $ 0.00 |
| Diluted EPS | $ 0.00 | $ 0.00 | $ 0.00 | $ -0.00 | $ 0.00 |
| Weighted Average Shares Outstanding | 381.21M | 381.21M | 76.21M | 76.21M | 76.21M |
| Weighted Average Shares Outstanding (Diluted) | 381.21M | 381.21M | 76.21M | 76.21M | 76.21M |
Currency in USD